Agency logo

Home

Influenza Arrives in Maine

Influenza has arrived in Maine. Multiple Maine facilities reported influenza positive rapid results in recent weeks, and Maine's Health and Environmental Testing Laboratory (HETL) has just confirmed two cases using real-time reverse transcription-polymerase chain reaction (real time-RT PCR) testing. Both specimens tested positive for influenza A/H3. These individuals are adults who were not hospitalized. One patient was unvaccinated, and the vaccine status remains unknown for the other.

Increased Respiratory Syncytial Virus (RSV) Activity in Maine

Respiratory syncytial virus (RSV) is circulating in Maine at a higher rate than usual for this time of year. Health care providers should consider testing patients with acute respiratory illness for RSV. To prevent transmission of RSV and other respiratory viruses, people with respiratory symptoms should refrain from in-person work, school, or daycare while acutely ill. This recommendation applies even if they have tested negative for SARS-CoV-2, the virus that causes COVID-19.

Use of an additional mRNA COVID-19 vaccine dose after an initial 2-dose primary mRNA COVID-19 vaccine series for immunocompromised people

On August 12, 2021, the U.S. Food and Drug Administration modified the Emergency Use Authorizations (EUAs) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to allow for administration of an additional dose (i.e., a third dose) of an mRNA COVID-19 vaccine after an initial 2-dose primary mRNA COVID-19 vaccine series for certain immunocompromised people.

Subscribe to